Your shopping cart is currently empty

(2R)-Octyl-α-hydroxyglutarate is a modified derivative of the D-isomer of 2-hydroxyglutarate. (2R)-Octyl-α-hydroxyglutarate can improve adenine-induced arterial calcification in rats and inhibit pancreatic tissue damage, making it suitable for research on vascular calcification (VC) and acute pancreatitis.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | - | In Stock | |
| 5 mg | $123 | - | In Stock | |
| 10 mg | $197 | - | In Stock | |
| 25 mg | $382 | - | In Stock | |
| 50 mg | $569 | - | In Stock | |
| 100 mg | $816 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $133 | - | In Stock |
| Description | (2R)-Octyl-α-hydroxyglutarate is a modified derivative of the D-isomer of 2-hydroxyglutarate. (2R)-Octyl-α-hydroxyglutarate can improve adenine-induced arterial calcification in rats and inhibit pancreatic tissue damage, making it suitable for research on vascular calcification (VC) and acute pancreatitis. |
| In vitro | Methods: IDH1 wild-type (IDH1-WT) HeLa cells were treated with (2R)-Octyl-α-hydroxyglutarate. Results: This compound dose-dependently increased the number of double-strand breaks (DSBs) in cells at the logarithmic growth phase, and is commonly used to investigate the effect of D-2-hydroxyglutarate on mitochondrial oxidative processes in IDH1-mutated cancer cells. |
| Synonyms | (2R)-Octyl-2-HG |
| Molecular Weight | 260.33 |
| Formula | C13H24O5 |
| Cas No. | 1391194-67-4 |
| Smiles | C([C@@H](CCC(O)=O)O)(OCCCCCCCC)=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (307.3 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (12.68 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.